Supplementary figure 1 (S1): Sequence logo depicting the position of cysteines in Cdr1p and their conservation among 22 fungal ABC transporters having.

Slides:



Advertisements
Similar presentations
BY4742  yhr087w YPDYP25YPD KCl 1MYP30 S.1 Defects of the YHR087W deletion mutant under osmotic stress conditions. Growth of the BY4742 and  yhr087w strains.
Advertisements

Styrylquinolines inhibit the ABC transporters of Candida albicans
Drug concentration (μM)
Dietmar Krautwurst, King-Wai Yau, Randall R Reed  Cell 
Expression levels from the HIS3 gene and growth during histidine starvation are optimised by the natural HIS3 codon usage in yeast Start codon clearance.
Ada Ndoja, Robert E. Cohen, Tingting Yao  Molecular Cell 
Volume 20, Issue 10, Pages (September 2017)
Volume 140, Issue 5, Pages (May 2011)
Usa1 Functions as a Scaffold of the HRD-Ubiquitin Ligase
Volume 44, Issue 4, Pages (November 2011)
Volume 22, Issue 4, Pages (February 2012)
Volume 19, Issue 1, Pages (January 2016)
Cut8, essential for anaphase, controls localization of 26S proteasome, facilitating destruction of cyclin and Cut2  Hisashi Tatebe, Mitsuhiro Yanagida 
Ali Zarrinpar, Roby P Bhattacharyya, M.Paige Nittler, Wendell A Lim 
Andreas Martin, Tania A. Baker, Robert T. Sauer  Molecular Cell 
Fluoxetine-Resistant Mutants in C
Testing the iGM insertion module.
Volume 23, Issue 6, Pages (December 2012)
Volume 36, Issue 5, Pages (December 2009)
Hery Ratsima, Diego Serrano, Mirela Pascariu, Damien D’Amours 
Volume 127, Issue 1, Pages (October 2006)
The complex containing actin-related proteins Arp2 and Arp3 is required for the motility and integrity of yeast actin patches  Dirk Winter, Alexandre.
John T. Arigo, Daniel E. Eyler, Kristina L. Carroll, Jeffry L. Corden 
Andrew J Henderson, Ruth I Connor, Kathryn L Calame  Immunity 
A Class of Membrane Proteins Shaping the Tubular Endoplasmic Reticulum
Volume 122, Issue 5, Pages (September 2005)
Markus Zettl, Michael Way  Current Biology 
Dmitry Zabezhinsky, Boris Slobodin, Doron Rapaport, Jeffrey E. Gerst 
Lucy S. Drury, John F.X. Diffley  Current Biology 
Volume 11, Issue 3, Pages (April 2015)
Supplementary Figures
Volume 8, Issue 5, Pages (February 1998)
Volume 70, Issue 2, Pages e6 (April 2018)
Volume 25, Issue 4, Pages (February 2015)
Rewiring Mid1p-Independent Medial Division in Fission Yeast
Volume 26, Issue 1, Pages (April 2007)
Emma L. Wise, PhD, Kandace T. Bonner, BSc, Timothy J
Terunao Takahara, Tatsuya Maeda  Molecular Cell 
Junbiao Dai, Weiwu Xie, Troy L. Brady, Jiquan Gao, Daniel F. Voytas 
A Role for the Fizzy/Cdc20 Family of Proteins in Activation of the APC/C Distinct from Substrate Recruitment  Yuu Kimata, Joanne E. Baxter, Andrew M.
A Link between ER Tethering and COP-I Vesicle Uncoating
Haploinsufficiency at the Nkx3.1 locus
Kenji Shimada, Susan M. Gasser  Cell 
Volume 17, Issue 10, Pages (October 2010)
Volume 33, Issue 5, Pages (March 2009)
Volume 21, Issue 15, Pages (August 2011)
Volume 23, Issue 8, Pages (May 2018)
Involvement of PIAS1 in the Sumoylation of Tumor Suppressor p53
An E3-like Factor that Promotes SUMO Conjugation to the Yeast Septins
Irina Chernyakov, Felipe Santiago-Tirado, Anthony Bretscher 
Adrian Halme, Stacie Bumgarner, Cora Styles, Gerald R Fink  Cell 
Kristýna Kotýnková, Kuan-Chung Su, Stephen C. West, Mark Petronczki 
Table 1. Synaptotagmin Project Strains
Lysine residues in the cytoplasmic region of TfR are involved in the MARCH8-induced downregulation of TfR. Lysine residues in the cytoplasmic region of.
Volume 26, Issue 2, Pages (January 2016)
Exit from Mitosis in Budding Yeast
Antisense Transcription Controls Cell Fate in Saccharomyces cerevisiae
A Yeast Catabolic Enzyme Controls Transcriptional Memory
Volume 16, Issue 2, Pages (February 2009)
Septin ring formation and chitin-containing septum formation are aberrant in filaments formed in response to staurosporine. Septin ring formation and chitin-containing.
Volume 3, Issue 2, Pages (February 2013)
CRISPRi-based repression of the essential gene HSP90 in C. albicans.
Nicole Robbins, Michelle D. Leach, Leah E. Cowen  Cell Reports 
Stabilization of Cell Polarity by the C. elegans RING Protein PAR-2
Volume 11, Pages (January 2019)
Volume 13, Issue 20, Pages (October 2003)
BRCA1 sequence variants classified as pathogenic do not restore HR
Competition between the ATPase Prp5 and Branch Region-U2 snRNA Pairing Modulates the Fidelity of Spliceosome Assembly  Yong-Zhen Xu, Charles C. Query 
Misfolded Membrane Proteins Are Specifically Recognized by the Transmembrane Domain of the Hrd1p Ubiquitin Ligase  Brian K. Sato, Daniel Schulz, Phong.
GBM 112 and GBM 144 cells infected in vitro with HCMV resist growth inhibition by temozolomide. GBM 112 and GBM 144 cells infected in vitro with HCMV resist.
Presentation transcript:

Supplementary figure 1 (S1): Sequence logo depicting the position of cysteines in Cdr1p and their conservation among 22 fungal ABC transporters having the same topology as Cdr1p. NBD1 Residues TM4 ECL3 NBD2 Residues TM 9 T M 10 11 ECL6

Supplementary figure 2 (S2): A E C1056S C1091S A E STRAIN FLC ITR KTC MIC CYH ANI R6G Control 0.5 0.015 0.12 0.25 Cdr1p-GFP 64 4 2 1 32 C1056S C1091S C1106S C1294S C1336S C193S C1106S C1294S B C1336S C193S C1056S C1091S C1106S C1294S C1336S C193S YPD FLC ITR KTC MIC CYH ANI Cdr1p-GFP Contol R6G F Cdr1p-GFP Control C1056S C1091S C1336S C1294S C1106S C193S C D

Supplementary figure 2 (S2) legend: The drug-resistance profiles and functional assays of the mutants in which critical cysteines were replaced with serines. A, B: Microtitre (MIC80 in μg/ml) and spot assays showing the drug-resistance profile of susceptible cysteine mutants of Cdr1p-GFP in which cysteine was changed to serine. The microtitre and spot assays were performed with different drugs as described in Fig. 1. C, D: The R6G efflux and ATPase assays of the drug-sensitive mutant variants of Cdr1p-GFP in which cysteine was changed to serine. The ATPase and R6G efflux assays were performed as described previously [8]. E, F: Confocal imaging and immunoblot of GFP-tagged Cdr1p and its sensitive cysteine-mutant variants in which cysteines were replaced with serine [8]. Bar graphs with error bars (showing standard error of mean) in panel F are the average of percentage values of expression (compared to Cdr1p-GFP which is taken as 100%) from two independent experiments (n=2).

Cdr1p+drug Cysless- Cdr1p-GFP Cysless Cdr1p-GFP +10ng/ml cyclo Cysless Cdr1p-GFP +20ng/ml cyclo Cysless Cdr1p-GFP +30ng/ml cyclo Cysless Cdr1p-GFP +50ng/ml cyclo Cysless Cdr1p-GFP +60ng/ml cyclo Cysless Cdr1p-GFP +40ng/ml cyclo Supplementary figure 3 (S3): Confocal microscopy showing membrane localization of Cdr1p-GFP & Cysless Cdr1p-GFP 8 HOURS 10 HOURS 12 HOURS 14 HOURS 16 HOURS 18 HOURS A. Membrane localisation in presence of sub MIC80 values of cycloheximide B. Membrane localisation of cysless Cdr1p-GFP at different time points of growth as observed by confocal microscopy 4

Supplementary table 1 (ST-1): List of oligonucleotides used in this study Residue No. Location Primer Sequence C193A NBD1 5’ GGGAGACCCGGTGCTGGTGCATCCACATTGTTAAAGACC 3' C325A 5' GGTGCTAATATCCAAGCCTGGGATAATGCCACTAGAGGG 3' C363A 5' CCTTTAATTGCTATTTATCAAGCCTCTCAAGATGCCTATGATTTA 3’ C402A 5' TTTGAAAAGATGGGTTGGAAAGCCCCTCAAAGACAAACTACT3’ C462A 5' GATGAATATTTTGTTGAAGCCGAACGATCCAACACCAGG 3’ C632A TMD1 5' CTATTGGTTAATGGCTATTTGGTGTACATTTG 3' C635A 5' GGTTAATGTGTATTTGGGCTACATTTGTTATGTCCC 3’ C712A 5' CGGTCGTGAATTCCAAGCTGCTCAATATGTTCC 3‘ C732A 5' CGTTCAAATCAAGTGGCTACTGCAGTGGGGTC 3’ C907A NBD2 5' GACTACATTGTTGAATGCTTTATCTGAAAGAGTCAC 3‘ C1041A 5' CTGCCTGGTCGATTGCTAAATTGATGAGAAAG 3' C1056A 5' GGTCAAGCCATTTTGGCTACTATCCATCAACC 3' C1091A 5' GAATTAGGTGAAAACGCTCAAACCATGATC 3' C1106A 5' GGTGCTGATCCAGCTCCTAAGGAAGC 3' C1294A TMD2 5' CCATGGGTCAATTAGCTATGTCTTTCAGTG 3' C1336A 5' GTACCATAGCATTTTTCGCTTGGTATTATCCATTAG 3' C1357A 5' GTTATTTACTATGGCTTTGAATTTCTGTGGTG 3‘ C1361A 5' GTGTTTGAATTTCGCTGGTGTTTTAGCTG 3' C1380A 5' GGATTTTCATGTACAGAGCTAATCCATTCACTTATTTGG 3 C1402A 5' GCTAACACTTTTGTTAAAGCTGCTGAACGTGAATATG 3' C1418A 5' CCACCAAATGGTGAATCTGCTTCTACTTATTTGGATCC 3' C1441A 5' CTAGAAATGATGGATCTGCTGCATTCTGTCAAATGAG 3' C1444A 5’ GGATCTTGTGCATTCGCTCAAATGAGTTCCACC 3' CDR1F 5' GCTACACTAGTATGTCAGATTCTAAGATGTCGTCG 3’ HR2 5'CTGACACTAGTTTAGTGATGGTGATGATGGTGATGCGCTGCTTTCTTATTTTTTTTCTCTCTGTTAC 3’

Supplementary table 2 (ST-2): List of yeast strains used in this study. Description Rrference AD1-8u- PSCDR1-GFP C193A-GFP C325A-GFP C363A-GFP C402A-GFP C462A-GFP C632A-GFP C635A-GFP C712A-GFP C732A-GFP C907A-GFP C1041A-GFP C1056A-GFP C1091A-GFP C1106A-GFP C1294A-GFP C1336A-GFP C1357A-GFP C1361A-GFP C1380A-GFP C1402A-GFP C1418A-GFP C1441A-GFP C1444A-GFP C193S-GFP C1056S-GFP C1091S-GFP C1106S-GFP C1294S-GFP C1336S-GFP Cysless CDR1-GFP Cysless CDR1-His MATa pdr1-3 hisG ura3 Äyor1::hisG Äsnq2::hisG Äpdr10::hisG Äpdr11::hisG Äycf1::hisG Äpdr15::hisG MATa pdr1-3 hisG ura3 Äyor1::hisG Äsnq2::hisG Äpdr10:: PDR5PROM-CDR1-GFP-GFPSTOP Äpdr11::hisG Äycf1::hisG Äpdr15::hisG CDR1-GFP cells carrying C193A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C325A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C363A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C402A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C462A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C632A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C635A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C712A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C732A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C907A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1041A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1056A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1091A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1106A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1294A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1336A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1357A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1361A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1380A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1402A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1418A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1441A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1444A mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C193S mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1056S mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1091S mutation in CDR1 ORF and integrated atPDR5 locus CDR1-GFP cells carrying C1106S mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1294S mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells carrying C1336S mutation in CDR1 ORF and integrated at PDR5 locus CDR1-GFP cells with all native cysteines converted to alanine except C193, C1056, C1091, C1106, C1294, C1336 which are converted to serine integrated at PDR5 locus CDR1-His cells with all native cysteines converted to alanine except C193, C1056, C1091, C1106, C1294, C1336 which are converted to serine integrated at PDR5 locus [5] [8] This Study